Hjem › Alzheimers sykdom › North Carolina
Kliniske studier for Alzheimers sykdom i North Carolina
21 studier for Alzheimers sykdom søker deltakere på steder i North Carolina.
Byer i North Carolina
Offisiell studietekst (engelsk)
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- New Hope Clinical Research, Charlotte
- AMC Research, LLC, Matthews
RekruttererFase 2
Alder 55 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- West Clinical Research, Morehead City
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06937229A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Triad Clinical Trials - 515 College Rd, Greensboro
- AMC Research, LLC - Flourish - PPDS, Matthews
- West Clinical Research, Morehead City
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06585787Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Triad Clinical Trials, Greensboro
RekruttererFase 3
Alder 50 til 90 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- West Clinical Research, Morehead City
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07011745ADRC Clinical Cohort (Alzheimer's Disease)
- Duke University, Durham
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 25 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06703541Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- New Hope Clinical Research, Charlotte
- UNC Health REX Hospital, Raleigh
RekruttererFase 2
Alder 55 til 90 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- AMC Research, LLC ( Site 1006), Matthews
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07033494A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Duke University, Durham
RekruttererFase 1
Alder 50 til 85 · Alle kjønn · Oppdatert 24. aug. 2026 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- AMC Research, LLC, Matthews
RekruttererFase 3
Alder 60 til 85 · Alle kjønn · Oppdatert 20. aug. 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Duke University Medical Center, Durham
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06563895A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
- Flourish Research, Matthews
RekruttererFase 1/2
Alder 35 til 85 · Alle kjønn · Oppdatert 10. jul. 2026 · NCT05462106A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Monroe Biomedical Research, Monroe
RekruttererFase 3
Alder 55 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT07602582A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- UNC Hosp Invest Drug Serv Pharm, Chapel Hill
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 26. jun. 2026 · NCT07094516Olfactory Biopsies
- Duke University Health Center, Durham
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jun. 2026 · NCT07021040A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- Duke Early Phase Research Unit, Durham
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 45 til 85 · Alle kjønn · Oppdatert 4. jun. 2026 · NCT06657768Late Onset Alzheimer's Disease
- North Carolina State University, Raleigh
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 55 og eldre · Alle kjønn · Oppdatert 18. mai 2026 · NCT05010603Connect-Home: Alzheimer's Disease and Related Dementias
- University of North Carolina at Chapel Hill, Chapel Hill
Rekrutterer
Alder 19 og eldre · Alle kjønn · Oppdatert 30. mar. 2026 · NCT06840587Wake Forest Alzheimer's Disease Clinical Core
- Wake Forest Baptist Health, Winston-Salem
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 55 og eldre · Alle kjønn · Oppdatert 27. mar. 2026 · NCT03140865Retinal Imaging in Neurodegenerative Disease
- Duke University Medical Center, Durham
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 4. feb. 2026 · NCT03233646Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Matthews
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 2. feb. 2026 · NCT07105709Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.